We have recently introduced the Vital Signs CradleLife device, a first of its kind vital signs monitor, into our clinical work in Haiti! This new handheld device recently developed by researchers from Guy’s and St. Thomas’ and King’s College London measures the blood pressure and pulse of pregnant women, helping to detect early high blood pressure caused by preeclampsia or eclampsia as a women’s risk of shock due to post-partum bleeding.

According to the WHO around 800 women die during pregnancy and childbirth everyday. 99% of these deaths occur in low and middle-income countries such as Haiti. C2C’s strives to incorporate the most innovative medical tools and protocols to strengthen our antenatal care services. In resource-poor communities, closely monitoring blood pressure is absolutely essential to safe pregnancy.

The CradleLife device is accurate and easy-to-use by all levels of healthcare workers. It provides visual alerts emphasising that action must be taken for women presenting with at-risk hypertensive readings.

C2C is using this innovative, low-cost technology to improve the health care of our patients. We are very excited to have introduced this new device and look forward to the impact it will have on the health of our patients!